Tag: MHRA inspection

Implementing Statistical Stability Data to Support Drug Product Expiry In the pharmaceutical industry, ensuring drug product efficacy throughout its shelf life is paramount. One of the critical activities in achieving…

Addressing Challenges in Complying with Regulatory Expectations for Retest Periods of APIs The requirement for establishing stability profiles for Active Pharmaceutical Ingredients (APIs) can often lead to challenges in maintaining…

Preparing Effective Stability Justification for Emerging Markets Navigating the regulatory expectations for stability studies is crucial for pharmaceutical manufacturers, especially when preparing to enter ASEAN and other emerging markets. Understanding…

Understanding the Regulatory Requirements for Stability Data in WHO Prequalification Submissions In the fast-paced world of pharmaceutical manufacturing, adhering to regulatory expectations for stability studies is critical, especially for WHO…

Effective Management of Stability Commitments in Global Product Registrations Managing stability commitments is crucial for pharmaceutical professionals involved in global product registrations. This process ensures compliance with regulatory expectations for…

Addressing Common Issues in Meeting Regulatory Expectations for Stability Studies in Biologics and Vaccines In the highly regulated realm of pharmaceutical manufacturing, particularly when it comes to biologics and vaccines,…

Effective Strategies for Justifying Reduced Stability Testing in Pharmaceuticals In the fast-paced world of pharmaceutical development, the need for efficiency must be balanced with rigorous compliance with regulatory expectations for…

Addressing Stability Data Requirements for Packaging and Container Closure Modifications In the pharmaceutical industry, the integrity of drug products is paramount, and changes to packaging and container closures can introduce…

Effective Presentation of OOT and OOS Stability Trends for Regulatory Compliance In pharmaceutical manufacturing, establishing and maintaining compliance with regulatory expectations during stability studies is crucial for product lifecycle management.…

Addressing Temperature Excursions and Regulatory Expectations in Stability Studies Temperature excursions during pharmaceutical stability studies present a significant risk to product integrity. These deviations can lead to a deterioration of…

Creating an Inspection-Ready Stability Study File for Regulatory Audits The integrity of pharmaceutical products is paramount, and regulatory agencies have specific expectations surrounding stability studies to ensure this integrity over…

Addressing Common FDA 483 Observations in Stability Programs When regulatory agencies, like the FDA, issue 483 observations relating to stability programs, it signals significant concerns that can impact product quality…